Unresolved disorder model. using A ATOM 124 CB AILE A 15 15.090 -25.196 -9.435 0.50 39.57 C Unresolved disorder model. using A ATOM 125 CB BILE A 15 15.156 -25.285 -9.389 0.50 39.03 C Unresolved disorder model. using A ATOM 126 CG1AILE A 15 14.939 -26.717 -9.468 0.50 39.20 C Unresolved disorder model. using A ATOM 127 CG1BILE A 15 14.918 -24.280 -10.518 0.50 37.28 C Unresolved disorder model. using A ATOM 128 CG2AILE A 15 16.404 -24.796 -10.064 0.50 39.74 C Unresolved disorder model. using A ATOM 129 CG2BILE A 15 14.225 -26.493 -9.541 0.50 38.26 C Unresolved disorder model. using A ATOM 130 CD1AILE A 15 13.531 -27.205 -9.316 0.50 39.34 C Unresolved disorder model. using A ATOM 131 CD1BILE A 15 15.160 -24.842 -11.899 0.50 34.31 C Unresolved disorder model. using A ATOM 271 CB AGLU A 35 22.642 -31.095 -17.492 0.65 29.15 C Unresolved disorder model. using A ATOM 272 CB BGLU A 35 22.716 -31.019 -17.453 0.35 28.79 C Unresolved disorder model. using A ATOM 273 CG AGLU A 35 22.452 -31.589 -18.909 0.65 29.00 C Unresolved disorder model. using A ATOM 274 CG BGLU A 35 22.922 -32.287 -16.648 0.35 27.53 C Unresolved disorder model. using A ATOM 275 CD AGLU A 35 21.387 -32.655 -19.024 0.65 31.15 C Unresolved disorder model. using A ATOM 276 CD BGLU A 35 21.876 -33.328 -16.959 0.35 28.29 C Unresolved disorder model. using A ATOM 277 OE1AGLU A 35 21.073 -33.255 -17.954 0.65 28.16 O Unresolved disorder model. using A ATOM 278 OE1BGLU A 35 21.969 -33.932 -18.053 0.35 28.25 O Unresolved disorder model. using A ATOM 279 OE2AGLU A 35 20.867 -32.893 -20.175 0.65 25.24 O Unresolved disorder model. using A ATOM 280 OE2BGLU A 35 20.972 -33.542 -16.116 0.35 25.67 O Unresolved disorder model. using A ATOM 303 N APRO A 39 13.762 -33.867 -9.245 0.50 32.16 N Unresolved disorder model. using A ATOM 304 N BPRO A 39 13.752 -33.833 -9.276 0.50 30.80 N Unresolved disorder model. using A ATOM 305 CA APRO A 39 13.264 -34.949 -8.349 0.50 32.26 C Unresolved disorder model. using A ATOM 306 CA BPRO A 39 13.009 -34.924 -8.653 0.50 29.89 C Unresolved disorder model. using A ATOM 307 C APRO A 39 12.601 -36.227 -8.919 0.50 32.21 C Unresolved disorder model. using A ATOM 308 C BPRO A 39 12.120 -35.694 -9.625 0.50 29.17 C Unresolved disorder model. using A ATOM 309 O APRO A 39 12.946 -37.338 -8.491 0.50 33.10 O Unresolved disorder model. using A ATOM 310 O BPRO A 39 11.652 -35.134 -10.633 0.50 27.86 O Unresolved disorder model. using A ATOM 311 CB APRO A 39 12.283 -34.208 -7.413 0.50 32.44 C Unresolved disorder model. using A ATOM 312 CB BPRO A 39 12.149 -34.206 -7.595 0.50 30.38 C Unresolved disorder model. using A ATOM 313 CG APRO A 39 11.895 -32.972 -8.165 0.50 32.44 C Unresolved disorder model. using A ATOM 314 CG BPRO A 39 12.027 -32.799 -8.095 0.50 30.49 C Unresolved disorder model. using A ATOM 315 CD APRO A 39 13.118 -32.574 -8.931 0.50 31.97 C Unresolved disorder model. using A ATOM 316 CD BPRO A 39 13.333 -32.514 -8.757 0.50 30.43 C Unresolved disorder model. using A ATOM 317 N AGLY A 40 11.657 -36.098 -9.846 0.50 31.45 N Unresolved disorder model. using A ATOM 318 N BGLY A 40 11.931 -36.981 -9.311 0.50 27.88 N Unresolved disorder model. using A ATOM 319 CA AGLY A 40 10.851 -37.258 -10.248 0.50 29.70 C Unresolved disorder model. using A ATOM 320 CA BGLY A 40 10.948 -37.835 -9.947 0.50 27.52 C Unresolved disorder model. using A ATOM 321 C AGLY A 40 11.282 -38.020 -11.506 0.50 28.31 C Unresolved disorder model. using A ATOM 322 C BGLY A 40 11.346 -38.426 -11.294 0.50 27.14 C Unresolved disorder model. using A ATOM 323 O AGLY A 40 12.450 -37.974 -11.916 0.50 27.49 O Unresolved disorder model. using A ATOM 324 O BGLY A 40 12.538 -38.561 -11.621 0.50 26.50 O Unresolved disorder model. using A ATOM 494 CB AGLN A 61 4.039 -31.682 -10.655 0.65 31.02 C Unresolved disorder model. using A ATOM 495 CB BGLN A 61 4.121 -31.760 -10.669 0.35 30.25 C Unresolved disorder model. using A ATOM 496 CG AGLN A 61 2.632 -31.898 -11.280 0.65 32.94 C Unresolved disorder model. using A ATOM 497 CG BGLN A 61 2.982 -32.390 -11.492 0.35 29.66 C Unresolved disorder model. using A ATOM 498 CD AGLN A 61 1.683 -30.699 -11.107 0.65 36.70 C Unresolved disorder model. using A ATOM 499 CD BGLN A 61 2.306 -33.569 -10.812 0.35 30.02 C Unresolved disorder model. using A ATOM 500 OE1AGLN A 61 1.855 -29.880 -10.208 0.65 37.48 O Unresolved disorder model. using A ATOM 501 OE1BGLN A 61 2.916 -34.625 -10.605 0.35 29.33 O Unresolved disorder model. using A ATOM 502 NE2AGLN A 61 0.670 -30.601 -11.980 0.65 39.43 N Unresolved disorder model. using A ATOM 503 NE2BGLN A 61 1.027 -33.401 -10.489 0.35 30.44 N Unresolved disorder model. using A ATOM 955 CB AGLU B 121 2.208 -13.744 -39.246 0.35 31.13 C Unresolved disorder model. using A ATOM 956 CB BGLU B 121 2.083 -13.613 -39.190 0.65 31.48 C Unresolved disorder model. using A ATOM 957 CG AGLU B 121 1.725 -14.182 -37.840 0.35 31.34 C Unresolved disorder model. using A ATOM 958 CG BGLU B 121 1.177 -13.506 -37.921 0.65 31.94 C Unresolved disorder model. using A ATOM 959 CD AGLU B 121 0.679 -15.314 -37.872 0.35 32.71 C Unresolved disorder model. using A ATOM 960 CD BGLU B 121 0.204 -12.295 -37.861 0.65 35.14 C Unresolved disorder model. using A ATOM 961 OE1AGLU B 121 1.018 -16.446 -38.278 0.35 32.97 O Unresolved disorder model. using A ATOM 962 OE1BGLU B 121 0.032 -11.528 -38.853 0.65 33.19 O Unresolved disorder model. using A ATOM 963 OE2AGLU B 121 -0.487 -15.079 -37.471 0.35 31.77 O Unresolved disorder model. using A ATOM 964 OE2BGLU B 121 -0.395 -12.099 -36.765 0.65 34.74 O Unresolved disorder model. using A ATOM 1153 CB AMET B 146 27.193 -18.186 -37.610 0.65 40.94 C Unresolved disorder model. using A ATOM 1154 CB BMET B 146 27.242 -18.136 -37.596 0.35 40.08 C Unresolved disorder model. using A ATOM 1155 CG AMET B 146 26.862 -19.626 -37.405 0.65 42.23 C Unresolved disorder model. using A ATOM 1156 CG BMET B 146 27.125 -19.652 -37.501 0.35 39.02 C Unresolved disorder model. using A ATOM 1157 SD AMET B 146 28.316 -20.612 -37.421 0.65 49.53 S Unresolved disorder model. using A ATOM 1158 SD BMET B 146 26.955 -20.460 -39.105 0.35 38.21 S Unresolved disorder model. using A ATOM 1159 CE AMET B 146 28.757 -20.572 -39.170 0.65 49.02 C Unresolved disorder model. using A ATOM 1160 CE BMET B 146 28.597 -20.252 -39.796 0.35 39.11 C Unresolved disorder model. using A ATOM 1272 CB AGLN B 161 19.945 0.755 -42.525 0.65 36.14 C Unresolved disorder model. using A ATOM 1273 CB BGLN B 161 20.017 0.791 -42.387 0.35 35.31 C Unresolved disorder model. using A ATOM 1274 CG AGLN B 161 20.972 1.494 -41.717 0.65 37.24 C Unresolved disorder model. using A ATOM 1275 CG BGLN B 161 20.896 1.468 -41.323 0.35 33.62 C Unresolved disorder model. using A ATOM 1276 CD AGLN B 161 22.365 1.285 -42.254 0.65 41.21 C Unresolved disorder model. using A ATOM 1277 CD BGLN B 161 21.986 2.374 -41.874 0.35 31.91 C Unresolved disorder model. using A ATOM 1278 OE1AGLN B 161 23.340 1.431 -41.521 0.65 43.75 O Unresolved disorder model. using A ATOM 1279 OE1BGLN B 161 22.479 3.251 -41.167 0.35 27.74 O Unresolved disorder model. using A ATOM 1280 NE2AGLN B 161 22.473 0.948 -43.553 0.65 41.34 N Unresolved disorder model. using A ATOM 1281 NE2BGLN B 161 22.383 2.158 -43.131 0.35 32.24 N Unresolved disorder model. using A ATOM 1310 CB AGLU B 165 5.391 -0.640 -40.385 0.65 31.05 C Unresolved disorder model. using A ATOM 1311 CB DGLU B 165 5.398 -0.578 -40.353 0.35 30.26 C Unresolved disorder model. using A ATOM 1312 CG AGLU B 165 5.941 0.106 -41.607 0.65 34.16 C Unresolved disorder model. using A ATOM 1313 CG DGLU B 165 4.482 0.413 -39.639 0.35 29.45 C Unresolved disorder model. using A ATOM 1314 CD AGLU B 165 4.875 0.925 -42.299 0.65 37.25 C Unresolved disorder model. using A ATOM 1315 CD DGLU B 165 3.195 0.696 -40.391 0.35 30.00 C Unresolved disorder model. using A ATOM 1316 OE1AGLU B 165 3.924 1.361 -41.605 0.65 37.11 O Unresolved disorder model. using A ATOM 1317 OE1DGLU B 165 2.966 0.102 -41.463 0.35 30.19 O Unresolved disorder model. using A ATOM 1318 OE2AGLU B 165 4.990 1.121 -43.534 0.65 39.28 O Unresolved disorder model. using A ATOM 1319 OE2DGLU B 165 2.402 1.522 -39.906 0.35 31.37 O 1